These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14655490)

  • 21. Effects of ingested turmeric oleoresin on glucose and lipid metabolisms in obese diabetic mice: a DNA microarray study.
    Honda S; Aoki F; Tanaka H; Kishida H; Nishiyama T; Okada S; Matsumoto I; Abe K; Mae T
    J Agric Food Chem; 2006 Nov; 54(24):9055-62. PubMed ID: 17117790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effects of alpha-linolenic acid on the functioning of the isolated heart during acute myocardial ischemia/reperfusion].
    Kukoba TV; Shysh AM; Moĭbenko OO; Kotsiuruba AV; Kharchenko OV
    Fiziol Zh (1994); 2006; 52(5):12-20. PubMed ID: 17176834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are alternative supplements effective treatment for diabetes mellitus?
    Kasuli EG
    Nutr Clin Pract; 2011 Jun; 26(3):352-5. PubMed ID: 21586420
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucose-lowering therapy after myocardial infarction: more questions than answers.
    Radke PW; Schunkert H
    Eur Heart J; 2008 Jan; 29(2):141-3. PubMed ID: 18199566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Goldilocks and the three bonds: new evidence for the conditional benefits of dietary α-linolenic acid in treating cardiovascular risk in the metabolic syndrome.
    Griffin BA
    Br J Nutr; 2012 Aug; 108(4):579-80. PubMed ID: 22894910
    [No Abstract]   [Full Text] [Related]  

  • 26. Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
    Elias AN; Eng S
    Diabetes Obes Metab; 2005 Mar; 7(2):117-21. PubMed ID: 15715884
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes mellitus: an imperative for prevention and intense management.
    Prisant LM
    J Clin Pharmacol; 2004 Apr; 44(4):394-6. PubMed ID: 15051747
    [No Abstract]   [Full Text] [Related]  

  • 28. Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.
    Verma S; Leiter LA; Lonn EM; Strauss MH
    Eur Heart J; 2005 Jul; 26(14):1347-9. PubMed ID: 15872030
    [No Abstract]   [Full Text] [Related]  

  • 29. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus.
    Tahrani AA
    Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin and Diabetes Mellitus: revisiting an old player.
    Manrique C; Lastra G; Palmer J; Gardner M; Sowers JR
    Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):37-42. PubMed ID: 19124406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
    Wiersma JJ; Trip MD; Piek JJ
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
    Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
    Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial.
    Johansen OE; Gullestad L; Blaasaas KG; Orvik E; Birkeland KI
    Diabet Med; 2007 Sep; 24(9):1019-27. PubMed ID: 17509068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus.
    Suchanek H; Myśliwska J; Siebert J; Wieckiewicz J; Hak Ł; Szyndler K; Kartanowicz D
    Eur Cytokine Netw; 2005 Sep; 16(3):177-85. PubMed ID: 16266856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter by Santos et al regarding article, "Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease".
    Santos MT; Moscardo A; Vallés J
    Circ Cardiovasc Interv; 2011 Aug; 4(4):e31; author reply e32. PubMed ID: 21846893
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe exacerbation of rosacea induced by cinnamon supplements.
    Campbell TM; Neems R; Moore J
    J Drugs Dermatol; 2008 Jun; 7(6):586-7. PubMed ID: 18561592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic atherothrombosis: helpful adjunctive therapy.
    Chesebro JH
    Eur Heart J; 2008 Sep; 29(18):2191-2. PubMed ID: 18689803
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of coronary artery disease in patients with (a)symptomatic diabetes.
    Bax JJ; van der Wall EE
    Eur Heart J; 2006 Mar; 27(6):631-2. PubMed ID: 16497691
    [No Abstract]   [Full Text] [Related]  

  • 39. Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
    Thomason MJ; Colhoun HM; Livingstone SJ; Mackness MI; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Fuller JH;
    Diabet Med; 2004 Aug; 21(8):901-5. PubMed ID: 15270795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiazolidinediones and cardiovascular outcomes in type 2 diabetes.
    Singh S; Furberg CD
    Heart; 2009 Jan; 95(1):1-3. PubMed ID: 18753156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.